Back to news | 30th September 2026
Earlier this year, we shared why Skytrail is proud to support Heart Cells Foundation and its work to advance cardiac regenerative medicine. The charity supports pioneering research and a dedicated clinical programme exploring the potential of stem cell therapy for people living with heart failure.
Now, a patient story recently featured in The Telegraph has provided a powerful insight into the human impact behind this work and the hope that continued research could offer patients and their families.
When everyday life changes
Following a heart attack in their 50s, one patient was left with significant damage to the heart muscle and subsequently experienced heart failure. Despite emergency treatment, ongoing medication and a gradual return to work, everyday activities that would once have been taken for granted became difficult.
Walking for extended periods was challenging, carrying a work bag could be difficult and returning to the active lifestyle they had previously enjoyed seemed a long way off.
While researching whether other treatment options might be available, the patient discovered the work of Heart Cells Foundation and a clinical programme exploring the potential of stem cell treatment for damaged hearts.
After being assessed as eligible, the patient underwent an experimental treatment using stem cells harvested from their own bone marrow. The cells were processed in a specialist laboratory before being delivered back to the heart.
A story of hope
In the months following the treatment, the patient reported improvements in their energy levels, mobility and ability to enjoy everyday activities again. This included travelling abroad, carrying their own luggage and gradually rebuilding their walking stamina.
While the treatment remains experimental and further clinical assessment is important, experiences like this provide a human perspective on why continued research into regenerative heart medicine matters.
Behind clinical programmes, research and medical innovation are people who want to get back to work, spend time with their families, travel, exercise and enjoy the everyday experiences that illness can take away. It is this human impact that makes the work of Heart Cells Foundation so important to us.
Putting people at the heart of innovation
Heart Cells Foundation funds work in cardiac regenerative medicine, alongside leading cardiologists and researchers exploring new approaches for people living with heart failure.
Its ambition is to help advance this field and support the journey towards making new treatment possibilities more widely available in the future.
For Skytrail, being part of that journey means looking beyond the science to the individuals and families who could ultimately benefit.
Patient experiences such as this, offer an encouraging glimpse of why continued progress matters. There is still work to be done, but every advance has the potential to take us another step towards new possibilities for people living with damaged hearts.
That is why Skytrail is proud to stand alongside Heart Cells Foundation and the people driving this work forward.
Find out more about Heart Cells Foundation and how you can support its work:
https://www.heartcellsfoundation.com/